Clinical follow-up using patient-reported outcome (PRO) for patients with lymphoma and chronic lymphocytic leukemia in a hematological outpatient clinic: a Danish prospective study
Remote monitoring through patient-reported outcomes works well for lymphoma and leukemia patients in remission, potentially freeing up hospital capacity.
This Danish prospective study evaluates AmbuFlex-based patient-reported outcome follow-up as an alternative to face-to-face outpatient visits for lymphoma and CLL patients, demonstrating feasibility and patient acceptability in routine hematological practice. The approach supports shifting toward remote monitoring models that could free healthcare capacity while maintaining quality of care for hematological malignancy patients in remission.
What the study was
- Study design
- Prospective observational study
- Population
- Lymphoma and CLL patients in hematological outpatient clinic (Danish population)
- Category
- Public Health
- Maturity
- Exploratory
- Journal
- Scientific Reports
Why it surfaced
Prospective study on PRO-based remote follow-up for hematological malignancies is practice-relevant; abstract-only limits confidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.